ASCO's CancerLinQ® and Atropos Health Collaborate to Harness Real-World Data to Provide Point-of-Care Informatics Consult to Oncologists

For immediate release
May 3, 2022


CancerLinQ CONTACT: Amanda Narod / ATROPOS HEALTH CONTACT: Chad Val Alstin
571-483-1795 / 941-281-5821

ALEXANDRIA, Va. and PALO ALTO, Ca. – ASCO's CancerLinQ® and Atropos Health announced today a new collaboration that will provide oncology clinicians with the latest real-world evidence available to help inform personalized care and treatment of an individual patient.

Atropos Health and CancerLinQ will work together to provide a “digital consult” to pressing clinical questions that are important in tailoring treatment decisions. Participating clinicians on the CancerLinQ platform will be able to request an on-demand analysis of millions of aggregated de-identified records of similar patient cases and outcomes, which will be delivered within days in the form of a “Prognostogram” report, leveraging best-in-class, peer-reviewed observational research methodologies.

“At CancerLinQ, we are guided by our commitment to deliver solutions to oncologists that improve the quality of care for patients in concrete and measurable ways,” said Sean Khozin, MD, MPH, chief executive officer of CancerLinQ LLC. “Our collaboration with Atropos Health will enable us to provide high-quality real-world evidence derived from diverse patient populations to help oncologist individualize treatment decisions at the point of care.”

“Atropos Health was founded to bring real-world evidence to providers, where care delivery can be impacted immediately with emerging data sets,” said Saurabh Gombar, MD, chief medical officer and co-founder at Atropos Health. “With CancerLinQ, we can bring insights directly to the clinic for vulnerable patients with cancer who need personalized, targeted care to maximize the chance of a positive outcome. Our goal is to ensure that this network of physicians has the tools and evidence to identify new treatments and deliver exceptional care to their patients.”

CancerLinQ’s products and services reflect a deep understanding of the needs of oncologists, cancer centers, and researchers. As a trusted partner to more than 100 cancer centers and community oncology practices, CancerLinQ is uniquely positioned to advance precision in cancer care delivery and research.

Atropos Health is the developer of the first physician informatics consultation service powered by research-grade real-world evidence. Using anonymized electronic patient records, Atropos Health helps patients, providers, health systems and research universities answer clinical questions by aggregating real-world data for similar patient cases.

To learn more about how oncologists are using real-world data to help provide better patient care and improve outcomes, click here.

About CancerLinQ:
CancerLinQ® is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the United States. CancerLinQ improves the quality of patient care and accelerates discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics (e.g., molecular profiles, comorbidities), treatments, and long-term side effects. By using data from over six million patients in near real time, CancerLinQ can identify trends and associations between myriad variables, thereby enabling physicians to generate new hypotheses and apply those conclusions to improve care in real-world settings. Follow CancerLinQ on Twitter or connect with us on LinkedIn.

About Atropos Health:
Atropos Health is the developer of the first physician consultation service powered by research-grade real-world evidence. Using millions of anonymized patient records, we help providers answer clinical questions that have fallen through the cracks of the evidence-based literature. To learn more about Atropos Health, visit or connect through LinkedIn and Twitter.

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.